A. F. Babu

Ketogenesis as a Metabolic Checkpoint in MASLD: Implications for Disease Progression and Therapy

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, encompassing a spectrum from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis and hepatocellular carcinoma. Increasing evidence indicates that disease prog...